Accelerant Holdings ARX Q1 2026 Earnings EPS Beat Drives Positive Investor Sentiment PRHIZ Q1 2024 Earnings Strong EPS Surprise Revenue Not Disclosed XPeng XPEV Q4 2025 Earnings Strong EPS Beat Fuels Positive Surprise Stock Edges Lower GOLD Q1 2026 Earnings EPS Crushes Estimates with 61 Surprise Yet Stock Dips Eupraxia Pharmaceuticals EPRX Q1 2026 Earnings Clinical Progress Overshadows Slight EPS Miss BKV Q1 2026 Earnings Earnings Miss Expectations as EPS Falls Short